Key facts
- This page summarizes Mark A. Stach's Form 4 filing for BALCHEM CORP (BCPC).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 Feb 2022, 08:15.
Mark A. Stach - 10 Feb 2022 Form 4 Insider Report for BALCHEM CORP (BCPC)
- Reporting relationship
- General Counsel
- Issuer ticker
- BCPC
- Reported as of
- 10 Feb 2022
- Net transaction value
- -$114,460
- SEC form
- 4
- Accepted by SEC
- 14 Feb 2022, 08:15:54 UTC
- Next SEC filing
- 15 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Stach
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark A. Stach filed Form 4 for BALCHEM CORP (BCPC) on 14 Feb 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$114,460.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BCPC
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +650
- Change %
- +9.2%
- Price
- $0.000000
- Shares after
- 7,691
- Date
- 10 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
BCPC
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,200
- Change %
- +29%
- Price
- $0.000000
- Shares after
- 9,891
- Date
- 10 Feb 2022
- Ownership
- Direct
- Footnotes
- F2
BCPC
transaction
Common Stock
Tax liability
- Transaction value
- $114,460
- Shares
- -829
- Change %
- -8.4%
- Price
- $138.07*
- Shares after
- 9,062
- Date
- 10 Feb 2022
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BCPC
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +2,200
- Change %
- +13%
- Price
- $0.000000
- Shares after
- 18,500
- Date
- 10 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,200
- Exercise price
- $138.07
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person.
Footnote F2
Acquired upon the settlement of performance shares granted on February 13, 2019, based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria.
Footnote F3
829 of the 2200 shares that vested February 10, 2022 were withheld to cover withholding taxes due upon vesting.
Footnote F4
Options vest 20% Year 1; 40% Year 2; and 40% Year 3.